[{"Assets_0_Q3_USD":6158090000.0,"CIK":"1048477","CommonStockSharesConverted_0_Q3_shares":181492344.0,"CommonStockSharesOutstanding_0_Q3_shares":181492344.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":4.33,"EarningsPerShareBasic_3_Q3_USD":4.63,"EarningsPerShareDiluted_1_Q3_USD":4.01,"EarningsPerShareDiluted_3_Q3_USD":4.39,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":98749000.0,"NetIncomeLossConverted_1_Q3_USD":784803000.0,"NetIncomeLossConverted_3_Q3_USD":837001000.0,"OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q3_USD":476784000.0,"RevenuesConverted_3_Q3_USD":1408338000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":4053893000.0,"Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":197674000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":194959000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":181142000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":180592000.0,"filed":"20201106","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2020.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20200930","qtrs":"3","uom":"USD"}]